Cargando…
Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco
We evaluated the performance of the Abbott BinaxNOW™ Covid-19 rapid antigen test to detect virus among persons, regardless of symptoms, at a public plaza site of ongoing community transmission. Titration with cultured clinical SARS-CoV-2 yielded a human observable threshold between 1.6×10(4)-4.3×10(...
Autores principales: | Pilarowski, Genay, Lebel, Paul, Sunshine, Sara, Liu, Jamin, Crawford, Emily, Marquez, Carina, Rubio, Luis, Chamie, Gabriel, Martinez, Jackie, Peng, James, Black, Douglas, Wu, Wesley, Pak, John, Laurie, Matthew T., Jones, Diane, Miller, Steve, Jacobo, Jon, Rojas, Susana, Rojas, Susy, Nakamura, Robert, Tulier-Laiwa, Valerie, Petersen, Maya, Havlir, Diane V., DeRisi, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654907/ https://www.ncbi.nlm.nih.gov/pubmed/33173911 http://dx.doi.org/10.1101/2020.11.02.20223891 |
Ejemplares similares
-
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco
por: Pilarowski, Genay, et al.
Publicado: (2021) -
High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco
por: Peng, James, et al.
Publicado: (2021) -
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
por: Peng, James, et al.
Publicado: (2021) -
Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020) -
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco
por: Peng, James, et al.
Publicado: (2021)